
Crezyme325 mg
Opsonin Pharma Ltd.

Tablet
Suzyme 325 mg is a preparation of Suzyme 325 mg having protease, lipase and amylase enzyme activity.
Suzyme 325 mg hydrolyses fats to glycerol and fatty acids, changes protein into proteoses and derived substances and converts starch into dextrins and sugars.
Suzyme 325 mg is employed in the conditions where the secretion of pancreatic juice is defcient.
What is Suzyme 325 mg used for?
Pancreatin is employed for the treatment of patients with Chronic pancreatitis Cystic fibrosis/Mucoviscidosis Following partial or complete pancreatectomy Total gastrectomy Steatorrhea Somatostatinoma Celiac disease and Other conditions associated with pancreatic insufficiency
What is the dosage of Suzyme 325 mg?
2-3 tablets to be swallowed whole with little water immediately after or during meal. Or as directed by the physician
What are the side effects of Suzyme 325 mg?
The most frequent side effects are gastrointestinal including nausea, vomiting and abdominal discomfort. Buccal and perianal soreness may occur, particularly in infants. Hypersensitivity reactions manifested by sneezing, lacrimation or skin rashes have been reported.
Who should not take Suzyme 325 mg?
Pancreatin is contraindicated in patients with known hypersensitivity to the drug.
What precautions should be taken with Suzyme 325 mg?
Patients known to be allergic to animal protein should be treated with caution.
Is Suzyme 325 mg safe during pregnancy and breastfeeding?
Pregnancy category C. Not known whether Pancreatin is distributed into milk. Caution advised if Pancreatin is used.
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.